Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-091384
Filing Date
2021-03-23
Accepted
2021-03-23 17:25:06
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d104226ds3.htm S-3 474332
2 EX-1.2 d104226dex12.htm EX-1.2 170221
3 EX-4.2 d104226dex42.htm EX-4.2 283465
4 EX-4.3 d104226dex43.htm EX-4.3 290702
5 EX-5.1 d104226dex51.htm EX-5.1 13882
6 EX-5.2 d104226dex52.htm EX-5.2 7166
7 EX-23.1 d104226dex231.htm EX-23.1 1847
8 GRAPHIC g104226g11d93.jpg GRAPHIC 60099
  Complete submission text file 0001193125-21-091384.txt   1325544
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-254637 | Film No.: 21765702
SIC: 2834 Pharmaceutical Preparations